Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1030250009Recruiting
Open-label, single-arm trial in hypertriglyceridemia, sponsored by Kowa Company, Ltd. Primary endpoints: Change in capillary arterial blood flow velocity at rest and Change in capillary arterial blood flow velocity during reactive hyperemia. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1030250009.